A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

NCT01322815 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Poor accrual rate

Conditions

Colon Cancer

Interventions

DRUG: chemotherapy and GI-4000
DRUG: GI-4000

Sponsor

Georgetown University

Collaborators

[object Object]